Ocular / rare disease gene thx. ADVM-022 in P1 OPTIC study in wAMD. Reported 24-wk data from cohort 1 (6 pts) in September (no rescue injections). 52-week data from cohort 1 and 24-week data from cohort 2 exp. 1H20. Collaborations in place with Regeneron and Editas.
Phase l or ll, Pre-Clinical Stage
Ophthalmology, Rare Disease
500MM - 1B
Menlo Park, California
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2019 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by